U.S. Consumer Finance Stock News

In early May 2026, PTC Therapeutics reported first-quarter revenue of US$272.55 million versus US$1.18 billion a year earlier, swinging from net income of US$866.56 million to a net loss of US$2.81 million while still beating analyst expectations on both revenue and earnings per share. The company also released positive 24-month interim data for Huntington’s disease therapy votoplam and raised its 2026 product revenue guidance, underscoring how a strong Sephience launch and advancing...

Southside Bancshares (SBSI) drew fresh attention after reporting first quarter 2026 results and affirming a quarterly dividend of $0.36 per share, pairing earnings information with a continued cash return to shareholders. See our latest analysis for Southside Bancshares. The recent first quarter update and confirmed dividend come after a steadily improving share price. The 1 month share price return was 5.12% and the year to date share price return was 10.51%, alongside a 1 year total...

Stock performance snapshot Stagwell (STGW) has quietly drawn attention after recent trading, with the stock last closing at US$6.46 and showing positive returns over the past week, month, past 3 months, and year to date. See our latest analysis for Stagwell. That recent 0.94% 1 day share price return fits into a stronger trend, with a 24.71% 3 month share price return and 29.33% 1 year total shareholder return suggesting momentum has been building rather than fading. If this kind of move has...

Why Excelerate Energy is on investors’ radar Excelerate Energy (EE) has drawn fresh attention after recent trading left the stock with a year to date total return of 19.58% and a 1 year total return of 17.62%, against a last close of US$33.89. See our latest analysis for Excelerate Energy. Recent trading has been choppy, with the share price up 2.5% on the day to US$33.89 but down over 13% on a 3 month share price return. This compares with a stronger 3 year total shareholder return of 62.2%,...

ManpowerGroup recently reported its Q1 2026 results, showing 10.3% revenue growth, significantly higher taxes that reduced net earnings to US$2.5 million, completion of the US$100 million sale of its Jefferson Wells U.S. finance and accounting business, and Board approval of a semi-annual US$0.72 per share dividend payable on June 15, 2026 to shareholders of record on June 1, 2026. Alongside these operational updates, shareholders approved an expanded and extended equity incentive plan and...

UFP Technologies (UFPT) just paired its Q1 2026 earnings with a clear push on acquisitions, as management highlighted a full deal pipeline, ongoing bids, and a disciplined filter on price, culture, and fit. See our latest analysis for UFP Technologies. The Q1 2026 earnings update and acquisition commentary have arrived alongside a sharp swing in sentiment, with a 19.7% 7 day share price return and a 14.6% 30 day share price return partly offsetting a 13.8% 90 day decline and leaving the 1...

Q1 earnings spark fresh interest in Lincoln Electric Holdings (LECO) Lincoln Electric Holdings (LECO) is back on investor radar after reporting first quarter sales of US$1,121.43 million and net income of US$136.38 million, both above the prior year period. See our latest analysis for Lincoln Electric Holdings. The earnings beat comes after a mixed share price run, with the stock up 11.22% year to date and delivering a 40.97% total shareholder return over one year. However, the 90 day share...

Fidelis Insurance Holdings Limited recently declared a quarterly dividend of US$0.15 per share, payable on June 26, 2026, following shareholder approval of bye-law amendments and ahead of its rebrand to Pelagos Insurance Capital Limited on May 11, 2026. Alongside this cash return, the company completed the repurchase of all remaining shares held by former principal shareholder CVC Falcon Holdings Limited, simplifying its ownership structure and removing a private equity governance...

In early May 2026, Crinetics Pharmaceuticals reported first-quarter revenue of about US$10.73 million, up sharply from roughly US$0.36 million a year earlier, alongside a wider net loss of about US$127.85 million and basic loss per share of US$1.23. Shortly before these results, the European Commission approved PALSONIFY (paltusotine) as the first once-daily oral therapy for adult acromegaly across the EU and EEA, reinforcing Crinetics’ shift into a commercial-stage rare disease business...

VNET Group recently announced a US$137.7 million follow-on equity offering at a steep discount and confirmed the past resignation of CFO Qiyu Wang, moves that have raised concerns about shareholder dilution and leadership continuity. The company was also removed from a major investment bank's Asia-Pacific Conviction List, highlighting wavering institutional confidence at a time when its financing choices are under scrutiny. Against this backdrop of discounted equity issuance, we'll now...

Ryerson Holding Corporation recently reported past first-quarter 2026 results, with sales rising to US$1,566.5 million and net income reaching US$4.5 million, alongside a return to positive earnings per share from continuing operations. On the same day, the company also filed a US$50.22 million shelf registration for 1,800,000 common shares tied to an ESOP-related offering, underscoring its use of equity for employee benefit plans. We will now examine how Ryerson’s return to profitability...

Taysha Gene Therapies (TSHA) has reaffirmed FDA alignment on the Biologics License Application pathway for TSHA-102, including pivotal trial design and the potential use of a six month interim analysis for approval. See our latest analysis for Taysha Gene Therapies. The reaffirmed FDA pathway comes after a run in the stock, with a 30 day share price return of 45.95% and a 1 year total shareholder return of 217.62%. This signals strong momentum despite recent earnings losses and ongoing cash...

Liberty Live Holdings, Inc. reported first-quarter 2026 results, with revenue rising to US$63.62 million from US$47.06 million a year earlier, while net loss widened to US$294.14 million from US$29.48 million. This combination of higher sales and a much larger loss highlights how Liberty Live Holdings is balancing growth with the cost of its operations. Next, we’ll examine how the sharp increase in net loss alongside revenue growth shapes Liberty Live Holdings’ broader investment...

The Buckle, Inc. recently reported that for the 4-week period ended May 2, 2026, comparable store net sales edged up 0.2% and total net sales rose to US$86.3 million, while year-to-date 13-week net sales increased to US$288.7 million. An interesting takeaway is that Buckle’s modest monthly comparable growth contrasts with a stronger 5.1% year-to-date comparable sales increase, highlighting resilience across the broader quarter. We’ll now examine how this solid 5.1% year-to-date comparable...

Huntsman Corporation recently reported first-quarter 2026 results showing sales of US$1,420 million and a net loss of US$53 million, while shareholders voted against a proposal for an independent board chair and the company affirmed a quarterly dividend of US$0.0875 per share. These developments, alongside ongoing restructuring and European plant-closure programs discussed in earlier filings, highlight the cost and governance pressures shaping Huntsman’s current operating profile. We’ll now...

TowneBank (TOWN) stock drew attention after recent trading left it modestly higher over the past week, but lower over the past month and over the past three months, prompting closer inspection of its fundamentals. See our latest analysis for TowneBank. At a share price of $34.99, TowneBank has a 1-day share price return of 0.46% and a year to date share price return of 5.33%, while its 3 year total shareholder return of 80.75% points to stronger momentum over the longer term. If TowneBank’s...

If you are wondering whether AGNC Investment at US$10.86 still offers value or if most of the opportunity is already priced in, this article walks through what the numbers are saying about the stock. The share price has returned 2.0% over the past week and 3.7% over the past month, while year to date the stock is down 0.6%. The 1 year and 3 year returns stand at 39.1% and 85.7% respectively, with a 17.5% return over 5 years. Recent coverage has focused on AGNC Investment's position within...

Host Hotels & Resorts (HST) is in focus after reporting first quarter 2026 results that exceeded profitability expectations, lifted its full year comparable hotel RevPAR guidance, and paired asset sale gains with a special dividend announcement. See our latest analysis for Host Hotels & Resorts. The share price has reacted positively to the first quarter update, with a 1 day share price return of 2.77% and a 7 day share price return of 6.76%. The 1 year total shareholder return of 49.75% and...

ArriVent BioPharma (AVBP) drew fresh attention after announcing FDA clearance of its investigational new drug application for ARR-002, a first-in-class dual-target antibody-drug conjugate for ovarian and endometrial cancers. See our latest analysis for ArriVent BioPharma. Despite a recent dip, with a 1 day share price return down 2.60% and 7 day share price return down 7.20%, ArriVent’s 30 day and year to date share price returns of 14.53% and 38.70%, alongside a 1 year total shareholder...

USA TODAY (TDAY) stock is in focus after the company returned to profitability in the first quarter of 2026, posting positive net income and reaffirming full year earnings guidance despite lower revenue. See our latest analysis for USA TODAY. The earnings return to profit and reaffirmed 2026 guidance have arrived alongside strong momentum, with a 90 day share price return of 26.96% and a 1 year total shareholder return of 105.66%, suggesting sentiment has strengthened around the earnings...

Rambus recently launched its PCIe 7.0 Switch IP with Time Division Multiplexing, expanding its interconnect portfolio to support bandwidth-intensive AI, cloud, and high-performance computing systems while aiming to improve link utilization and reduce system complexity for large-scale distributed architectures. This new switch IP strengthens Rambus’ position in high-speed interface IP by targeting emerging disaggregated and pooled compute designs that require deterministic, low-latency data...

If you are wondering whether Sonos stock still offers value after a strong run or a rough patch, this article breaks down what the current price might be telling you. Over the past year, the stock has returned 44.4%, compared with a 16.1% gain over the last 30 days, while year to date it is down 13.9% and the 5-year return sits at a 55.5% loss. Recent headlines around Sonos have focused on its role in the consumer audio market and how sentiment has shifted around the stock. These stories...

In early May 2026, Caris Life Sciences reported first-quarter revenue of US$216.17 million versus US$120.92 million a year earlier, with net loss improving to US$0.51 million, while also securing MolDX approval for its Caris ChromoSeq whole genome assay and launching the AI-driven Caris MI Clarity breast cancer prognostic test. Together, these developments highlight Caris’ efforts to broaden its precision oncology portfolio across hematologic malignancies and early-stage breast cancer, while...

SL Green Realty (SLG) is back in focus after its One Madison Avenue project received the 2026 Urban Land Institute Award for Excellence in Development and reached 100% leasing, alongside flagship peer asset One Vanderbilt. See our latest analysis for SL Green Realty. The award recognition comes as momentum in SL Green Realty’s stock has picked up, with a 6.77% 7 day share price return and a 20.55% 30 day share price return. The 1 year total shareholder return is a 14.13% loss, while the 3...